SJS/TEN 2019: From science to translation.

Autor: Chang WC; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada., Abe R; Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan., Anderson P; Stevens-Johnson Syndrome Foundation, Westminster, CO, USA., Anderson W; Stevens-Johnson Syndrome Foundation, Westminster, CO, USA., Ardern-Jones MR; Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK., Beachkofsky TM; Wilford Hall Ambulatory Surgical Center, Lackland Air Force Base, TX, USA., Bellón T; Drug Hypersensitivity Group, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain., Biala AK; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada., Bouchard C; Loyola University Medical Center, Chicago, IL, USA., Cavalleri GL; School of Pharmacy and Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland; FutureNeuro SFI Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland., Chapman N; SJS Awareness Oregon, Klamath Falls, OR, USA., Chodosh J; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Choi HK; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA., Cibotti RR; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, USA., Divito SJ; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Dewar K; Genome Canada, Ottawa, ON, Canada., Dehaeck U; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada., Etminan M; Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada., Forbes D; Canadian Institutes of Health Research, Ottawa, ON, Canada., Fuchs E; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA., Goldman JL; Children's Mercy Hospital Kansas City, Kansas City, MO, USA., Holmes JH 4th; Wake Forest University School of Medicine, WFBMC Burn Center, Winston-Salem, NC, USA., Hope EA; Genome British Columbia, Vancouver, BC, Canada., Hung SI; Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Immunology Consortium, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan; Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan., Hsieh CL; Eden Social Welfare Foundation, Taipei, Taiwan., Iovieno A; Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver General Hospital Eye Care Center, Vancouver, BC, Canada., Jagdeo J; Genome British Columbia, Vancouver, BC, Canada., Kim MK; Department of Ophthalmology, Seoul National University College of Medicine, Seoul, South Korea., Koelle DM; Department of Medicine, University of Washington, Seattle, WA, USA., Lacouture ME; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Le Pallec S; Association des malades des syndromes de Lyell et de Stevens-Johnson (Amalyste), Paris, France., Lehloenya RJ; Division of Dermatology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Lim R; Health Products and Food Branch, Health Canada, Ottawa, ON, Canada., Lowe A; SJS/TEN International Awareness (STIA), Lucky Lake, SK, Canada., McCawley J; Stevens-Johnson Syndrome Foundation, Westminster, CO, USA., McCawley J; Stevens-Johnson Syndrome Foundation, Westminster, CO, USA., Micheletti RG; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Mockenhaupt M; Dokumentationszentrum schwerer Hautreaktionen (dZh), Department of Dermatology, Medical Center and Medical Faculty, University of Freiburg, Freiburg, Germany., Niemeyer K; SJ Syndrome of Texas, Austin, TX, USA., Norcross MA; Laboratory of Immunology, Division of Biotechnology Review and Research III (DBRR III), Office of Biotechnology Products (OBP), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), FDA, Silver Spring, MD, USA., Oboh D; Stevens-Johnson Syndrome Foundation, Westminster, CO, USA., Olteanu C; Division of Dermatology, Department of Medicine, University of Alberta, Edmonton, AB, Canada., Pasieka HB; Department of Dermatology, MedStar Washington Hospital Center, Washington, DC, USA., Peter J; Division of Allergy and Clinical Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Pirmohamed M; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Rieder M; Department of Paediatrics, Children's Hospital/London Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada., Saeed HN; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Shear NH; Sunnybrook Health Sciences Centre, University of Toronto, ON, Canada., Shieh C; Department of Ophthalmology, Vanderbilt Eye Institute, Nashville, TN, USA., Straus S; Dutch Medicines Evaluation Board, Pharmacovigilance Risk Assessment Committee, European Medicines Agency, Utrecht, the Netherlands., Sukasem C; Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Sung C; Health Products Regulation Group, Health Sciences Authority Singapore, Duke-NUS Medical School, Singapore., Trubiano JA; Department of Infectious Diseases, Austin Health, Heidelberg, Germany; Department of Medicine, University of Melbourne, Victoria, Australia., Tsou SY; Eden Social Welfare Foundation, Taipei, Taiwan., Ueta M; Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan., Volpi S; National Human Genome Research Institute, NIH, Bethesda, MD, USA., Wan C; Genome British Columbia, Vancouver, BC, Canada., Wang H; Institute of Dermatology, Chinese Academy of Medical Sciences, National Center for STD and Leprosy Control, China CDC, Nanjing, China., Wang ZQ; Eden Social Welfare Foundation, Taipei, Taiwan., Weintraub J; Division of Pharmacovigilance I, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, USA., Whale C; SJS Canada, Brantford, ON, Canada., Wheatley LM; National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Whyte-Croasdaile S; SJS Canada, Brantford, ON, Canada., Williams KB; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Wright G; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada., Yeung SN; Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver General Hospital Eye Care Center, Vancouver, BC, Canada., Zhou L; Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Chung WH; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taipei, Keelung, Taoyuan, Taiwan; Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Immunology Consortium, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, Xiamen, China; Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan. Electronic address: chung1@cgmh.org.tw., Phillips EJ; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: elizabeth.j.phillips@vumc.org., Carleton BC; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada. Electronic address: bcarleton@popi.ubc.ca.
Jazyk: angličtina
Zdroj: Journal of dermatological science [J Dermatol Sci] 2020 Apr; Vol. 98 (1), pp. 2-12. Date of Electronic Publication: 2020 Mar 07.
DOI: 10.1016/j.jdermsci.2020.02.003
Abstrakt: Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are potentially life-threatening, immune-mediated adverse reactions characterized by widespread erythema, epidermal necrosis, and detachment of skin and mucosa. Efforts to grow and develop functional international collaborations and a multidisciplinary interactive network focusing on SJS/TEN as an uncommon but high burden disease will be necessary to improve efforts in prevention, early diagnosis and improved acute and long-term management. SJS/TEN 2019: From Science to Translation was a 1.5-day scientific program held April 26-27, 2019, in Vancouver, Canada. The meeting successfully engaged clinicians, researchers, and patients and conducted many productive discussions on research and patient care needs.
(Crown Copyright © 2020. Published by Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: